Oxidative stress via activating soluble guanylate cyclase leads to increased nitric oxide sensitivity of coronary arterioles in high fat diet-induced obesity

Oxidative stress via activating soluble guanylate cyclase leads to increased nitric oxide sensitivity of coronary arterioles in high fat diet-induced obesity

Detalhes bibliográficos
Principais autores:	Erdei, N, Feher, A, Beleznai, T, Edes, I, Koller, A, Bagi, Z
Formato:	Conference item
Publicado em:	2007

Registros relacionados

Increased soluble guanylate cyclase (sGC) activity may compensate for the high fat diet-induced reduction in NO bioavailability of rat coronary arterioles
por: Koller, A, et al.
Publicado em: (2007)

High-fat diet-induced obesity leads to increased NO sensitivity of rat coronary arterioles: role of soluble guanylate cyclase activation.
por: Jebelovszki, E, et al.
Publicado em: (2008)

O-Linked-n-Acetylglucosamine Formation Reduces Nitric Oxide-Dependent Dilation in Arterioles Exposed to High Glucose Concentrations
por: Beleznai, T, et al.
Publicado em: (2008)

The nitric oxide–soluble guanylate cyclase–cGMP pathway in pulmonary hypertension: from PDE5 to soluble guanylate cyclase
por: Raymond L. Benza, et al.
Publicado em: (2024-03-01)

Nitric oxide and hydrogen peroxide contribute to the development of reactive dilation in isolated coronary arterioles
por: Koller, A, et al.
Publicado em: (2004)

Allosteric activation of the nitric oxide receptor soluble guanylate cyclase mapped by cryo-electron microscopy
por: Benjamin G Horst, et al.
Publicado em: (2019-09-01)

Nitric oxide and H2O2 contribute to reactive dilation of isolated coronary arterioles.
por: Koller, A, et al.
Publicado em: (2004)

Multiple effects of diabetes mellitus on the vasomotor responses of human coronary arterioles
por: Bagi, Z, et al.
Publicado em: (2007)

Tetrahydrobiopterin protects soluble guanylate cyclase against oxidative inactivation
por: Schmidt Kurt, et al.
Publicado em: (2013-06-01)

Soluble guanylate cyclase mediates the relaxation of healthy and inflamed bladder smooth muscle by aqueous nitric oxide
por: Patrik Aronsson, et al.
Publicado em: (2023-09-01)

High-fat diet-induced reduction in nitric oxide-dependent arteriolar dilation in rats: role of xanthine oxidase-derived superoxide anion.
por: Erdei, N, et al.
Publicado em: (2006)

Adaptation of vasomotor function of human coronary arterioles to the simultaneous presence of obesity and hypertension.
por: Fulop, T, et al.
Publicado em: (2007)

Increased cyclooxygenase-2 expression and prostaglandin-mediated dilation in coronary arterioles of patients with diabetes mellitus.
por: Szerafin, T, et al.
Publicado em: (2006)

High intraluminal pressure reduces tachyphylaxis to angiotensin II in isolated arterioles
por: Koller, A, et al.
Publicado em: (2006)

Impaired flow-induced dilation in skeletal muscle arterioles of rats with hyperhomocysteinemia (HHCY). Role of nitric oxide and constrictor prostanoids.
por: Bagi, Z, et al.
Publicado em: (2000)

Nitric oxide — soluble guanylate cyclase — cyclic guanosine monophosphate signaling pathway in the pathogenesis of heart failure and search for novel therapeutic targets
por: Zh. D. Kobalava, et al.
Publicado em: (2021-10-01)

Interferon-γ augments GABA release in the developing neocortex via nitric oxide synthase/soluble guanylate cyclase and constrains network activity
por: Noah Döhne, et al.
Publicado em: (2022-08-01)

YC-1, a Nitric Oxide-Independent Activator of Soluble Guanylate Cyclase, Inhibits the Spontaneous Contractions of Isolated Pregnant Rat Myometrium
por: Ali Cetin, et al.
Publicado em: (2004-01-01)

Soluble guanylate cyclase stimulation reduces oxidative stress in experimental Chronic Obstructive Pulmonary Disease.
por: Tanja Paul, et al.
Publicado em: (2018-01-01)

Upregulation of Arginase I Reduces Nitric Oxide-mediated Coronary Arteriolar Dilation in Patients With Type 2 Diabetes
por: Bagi, Z, et al.
Publicado em: (2009)

Alteration of the soluble guanylate cyclase system in coronary arteries of high cholesterol diet‐fed rabbits
por: Masashi Tawa, et al.
Publicado em: (2021-08-01)

Flow-induced constriction in arterioles of hyperhomocysteinemic rats is due to impaired nitric oxide and enhanced thromboxane A(2) mediation.
por: Bagi, Z, et al.
Publicado em: (2001)

Replacement of heme by soluble guanylate cyclase (sGC) activators abolishes heme-nitric oxide/oxygen (H-NOX) domain structural plasticity
por: Aikaterini I. Argyriou, et al.
Publicado em: (2021-01-01)

Adaptation of coronary arteriolar dilations to the simultaneous presence of obesity and hypertension: Role of increased nitric oxide sensitivity
por: Bagi, Z, et al.
Publicado em: (2007)

Hydrogen peroxide elicits COX-2-dependent production of constrictor prostaglandins in arterioles of type 2 diabetic mice
por: Bagi, Z, et al.
Publicado em: (2005)

Crystal structures of the catalytic domain of human soluble guanylate cyclase
por: Allerston, C, et al.
Publicado em: (2013)

Soluble Guanylate Cyclase Activators as Potential Novel Pad Therapeutics
por: Shaunak Adkar, et al.
Publicado em: (2024-01-01)

Renal Soluble Guanylate Cyclase Is Downregulated in Sunitinib‐Induced Hypertension
por: Jeannine Witte, et al.
Publicado em: (2018-09-01)

Crystal structures of the catalytic domain of human soluble guanylate cyclase.
por: Charles K Allerston, et al.
Publicado em: (2013-01-01)

Activation mechanism of human soluble guanylate cyclase by stimulators and activators
por: Rui Liu, et al.
Publicado em: (2021-09-01)

PPARgamma activation, by reducing oxidative stress, increases NO bioavailability in coronary arterioles of mice with Type 2 diabetes.
por: Bagi, Z, et al.
Publicado em: (2004)

(6R)-5,6,7,8-Tetrahydro-L-Biopterin-Dependent Activation of Soluble Guanylate Cyclase in the Rat Cerebellum is Mediated by Nitric Oxide Formation
por: Nunokawa Y., et al.
Publicado em: (1991-02-01)

Conducted vasodilatation in human coronary arterioles
por: Bagi, Z, et al.
Publicado em: (2011)

Structures of soluble guanylate cyclase: implications for regulatory mechanisms and drug development.
por: Gileadi, O
Publicado em: (2014)

Stimulators and Activators of Soluble Guanylate Cyclase: Review and Potential Therapeutic Indications
por: Bobby Nossaman, et al.
Publicado em: (2012-01-01)

Antithrombotic Activity of an Indolinone Derivative – a Soluble Guanylate Cyclase Stimulator
por: V. V. Bykov, et al.
Publicado em: (2022-09-01)

Regulation of intraocular pressure by soluble and membrane guanylate cyclases and their role in glaucoma.
por: Emmanuel S Buys, et al.
Publicado em: (2014-05-01)

Regulation of Soluble Guanylate Cyclase by Matricellular Thrombospondins: Implications for Blood Flow
por: Natasha M Rogers, et al.
Publicado em: (2014-04-01)

Soluble guanylate cyclase stimulation: an emerging option in pulmonary hypertension therapy
por: H. A. Ghofrani, et al.
Publicado em: (2009-03-01)

Riociguat: a soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension
por: Lian TY, et al.
Publicado em: (2017-04-01)